TY - JOUR
T1 - Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function
AU - Chaliki, Hari P.
AU - Mohty, Dania
AU - Avierinos, Jean Francois
AU - Scott, Christopher G.
AU - Schaff, Hartzell V.
AU - Tajik, A. Jamil
AU - Enriquez-Sarano, Maurice
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2002/11/19
Y1 - 2002/11/19
N2 - Background - Left ventricular dysfunction is an indication for aortic valve replacement (AVR) in patients with severe aortic regurgitation (AR). However, the postoperative outcome of patients with severe AR and a markedly low ejection fraction (EF) is not known. Methods and Results - The study group consisted of a total of 450 patients who had AVR for isolated AR between 1980 and 1995. Patients with markedly reduced left ventricular function (EF <35%, LoEF, n=43) were compared with those with moderate reduction in left ventricular function (EF 35% to 50%, MedEF, n=134) and those with normal left ventricular function (EF ≥50%, Nl EF, n=273). The operative mortality rate was higher with LoEF (14%) than with MedEF and Nl EF (6.7% and 3.7%, respectively, P=0.02). At 10 years, 41%±9% of LoEF patients had survived compared with 56%±5% and 70%±3% of MedEF and Nl EF patients, respectively (P<0.0001). Congestive heart failure occurred at 10 years in 25%±9% with LoEF compared with 17%±4% and 9%±2% with MedEF and NL EF, respectively (P<0.003). Postoperative EF improved by 4.9%±13.8% in the LoEF group and by 4%±11.9% in the MedEF group compared with -2.3%±10.9% in the Nl EF group (P<0.002 and P<0.0001, respectively). Conclusions - Patients with severe AR and markedly low EF incur excess operative mortality rates, postoperative mortality rates, and congestive heart failure after AVR. However, postoperative EF improves markedly, and most patients enjoy a long postoperative survival without recurrence of heart failure after AVR; thus they should not be denied the benefits of AVR.
AB - Background - Left ventricular dysfunction is an indication for aortic valve replacement (AVR) in patients with severe aortic regurgitation (AR). However, the postoperative outcome of patients with severe AR and a markedly low ejection fraction (EF) is not known. Methods and Results - The study group consisted of a total of 450 patients who had AVR for isolated AR between 1980 and 1995. Patients with markedly reduced left ventricular function (EF <35%, LoEF, n=43) were compared with those with moderate reduction in left ventricular function (EF 35% to 50%, MedEF, n=134) and those with normal left ventricular function (EF ≥50%, Nl EF, n=273). The operative mortality rate was higher with LoEF (14%) than with MedEF and Nl EF (6.7% and 3.7%, respectively, P=0.02). At 10 years, 41%±9% of LoEF patients had survived compared with 56%±5% and 70%±3% of MedEF and Nl EF patients, respectively (P<0.0001). Congestive heart failure occurred at 10 years in 25%±9% with LoEF compared with 17%±4% and 9%±2% with MedEF and NL EF, respectively (P<0.003). Postoperative EF improved by 4.9%±13.8% in the LoEF group and by 4%±11.9% in the MedEF group compared with -2.3%±10.9% in the Nl EF group (P<0.002 and P<0.0001, respectively). Conclusions - Patients with severe AR and markedly low EF incur excess operative mortality rates, postoperative mortality rates, and congestive heart failure after AVR. However, postoperative EF improves markedly, and most patients enjoy a long postoperative survival without recurrence of heart failure after AVR; thus they should not be denied the benefits of AVR.
KW - Aorta
KW - Regurgitation
KW - Surgery
KW - Survival
KW - Valves
UR - http://www.scopus.com/inward/record.url?scp=0037137294&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037137294&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.0000038498.59829.38
DO - 10.1161/01.CIR.0000038498.59829.38
M3 - Article
C2 - 12438294
AN - SCOPUS:0037137294
SN - 0009-7322
VL - 106
SP - 2687
EP - 2693
JO - Circulation
JF - Circulation
IS - 21
ER -